Multi-drug resistant organism transmission US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Multi-drug resistant organism transmission. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Multi-drug resistant organism transmission US Medical PG Question 1: The surgical equipment used during a craniectomy is sterilized using pressurized steam at 121°C for 15 minutes. Reuse of these instruments can cause transmission of which of the following pathogens?
- A. Non-enveloped viruses
- B. Sporulating bacteria
- C. Prions (Correct Answer)
- D. Enveloped viruses
- E. Yeasts
Multi-drug resistant organism transmission Explanation: ***Prions***
- Prions are **abnormally folded proteins** that are highly resistant to standard sterilization methods like steam autoclaving at 121°C, making them a risk for transmission through reused surgical instruments.
- They cause transmissible spongiform encephalopathies (TSEs) like **Creutzfeldt-Jakob disease**, where even trace amounts can be highly infectious.
*Non-enveloped viruses*
- Non-enveloped viruses are generally **more resistant to heat and disinfectants** than enveloped viruses but are typically inactivated by recommended steam sterilization protocols.
- Standard autoclaving conditions are effective in destroying most non-enveloped viruses.
*Sporulating bacteria*
- **Bacterial spores**, such as those from *Clostridium* or *Bacillus*, are known for their high resistance to heat and chemicals, but are usually **inactivated by steam sterilization at 121°C** for 15 minutes.
- This method is specifically designed to kill bacterial spores effectively.
*Enveloped viruses*
- Enveloped viruses are the **least resistant to heat and chemical disinfectants** due to their lipid envelope.
- They are readily **inactivated by standard steam sterilization** at 121°C.
*Yeasts*
- **Yeasts** are eukaryotic microorganisms that are typically **susceptible to heat sterilization**.
- They are effectively killed by typical steam autoclaving conditions used for surgical instruments.
Multi-drug resistant organism transmission US Medical PG Question 2: A multicentric, ambidirectional cohort study (i.e. a study that combines elements of both prospective and retrospective cohort studies) was designed in order to evaluate the relationship between nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) and exposure to patients in intensive-care units of several tertiary hospital centers. The sample included 1,000 physicians who worked in the hospital environment and who willingly underwent swabbing of their nasal vestibule and nasopharynx for active surveillance. Data of their working location was obtained from hospital administrative services. Of those who worked in the intensive care unit, 350 were colonized with MRSA, while 250 were not. Whereas in those that worked in other hospital wards, 100 were colonized with MRSA, and 300 were not. What is the relative risk of MRSA colonization in relation to working in the intensive-care unit?
- A. 3.22
- B. 2.33 (Correct Answer)
- C. 0.43
- D. 1.66
- E. 0.18
Multi-drug resistant organism transmission Explanation: ***2.33***
- The relative risk (RR) is calculated as the incidence of the outcome in the exposed group divided by the incidence of the outcome in the unexposed group.
- In this case, the incidence of MRSA colonization in ICU workers is 350 / (350 + 250) = 350 / 600 = 0.5833. The incidence in non-ICU workers is 100 / (100 + 300) = 100 / 400 = 0.25. Therefore, the **RR = 0.5833 / 0.25 = 2.33**.
*3.22*
- This value is obtained if the calculation is performed incorrectly, for example, by misidentifying the exposed and unexposed groups or by incorrectly calculating the incidences.
- It does not reflect the correct ratio of MRSA colonization rates between the two groups.
*0.43*
- This value represents the **inverse of the relative risk** (1/2.33) if the exposed and unexposed groups were swapped in the calculation.
- It would suggest a protective effect of working in the ICU, which is not supported by the data.
*1.66*
- This value is a result of an incorrect calculation of the incidences in either the exposed or unexposed groups.
- It significantly underestimates the actual relative risk of MRSA colonization associated with working in an ICU.
*0.18*
- This value would arise from a substantial error in the calculation, possibly by inverting the incidences or using an inappropriate formula.
- It suggests a **strong protective effect** of ICU exposure, which is contrary to the observed data of higher colonization rates in ICU workers.
Multi-drug resistant organism transmission US Medical PG Question 3: A 12-month-old girl is brought to her pediatrician for a checkup and vaccines. The patient’s mother wants to send her to daycare but is worried about exposure to unvaccinated children and other potential sources of infection. The toddler was born at 39 weeks gestation via spontaneous vaginal delivery. She is up to date on all vaccines. She does not walk yet but stands in place and can say a few words. The toddler drinks formula and eats a mixture of soft vegetables and pureed meals. She has no current medications. On physical exam, the vital signs include: temperature 37.0°C (98.6°F), blood pressure 95/50 mm Hg, pulse 130/min, and respiratory rate 28/min. The patient is alert and responsive. The remainder of the exam is unremarkable. Which of the following is most appropriate for this patient at this visit?
- A. Meningococcal vaccine
- B. Gross motor workup and evaluation
- C. Rotavirus vaccine
- D. Referral for speech pathology
- E. MMR vaccine (Correct Answer)
Multi-drug resistant organism transmission Explanation: ***MMR vaccine***
- The **measles, mumps, and rubella (MMR) vaccine** is recommended for administration at **12-15 months of age**.
- This timing offers protection against these common childhood diseases, which is especially important for children attending **daycare**.
*Meningococcal vaccine*
- The routine **meningococcal vaccine (MenACWY)** is typically recommended for adolescents at **11-12 years of age**, with a booster at 16 years.
- While there are specific circumstances for earlier vaccination (e.g., high-risk conditions), it is **not routine** for a 12-month-old.
*Gross motor workup and evaluation*
- The patient's motor development, standing in place but not yet walking, is **within the normal range** for a 12-month-old.
- A definitive **gross motor workup** would generally be considered if there were more significant delays or regressions.
*Rotavirus vaccine*
- The **rotavirus vaccine** series is typically given at **2, 4, and 6 months of age**, with the final dose administered no later than **8 months of age**.
- A 12-month-old is **outside the recommended age range** for initiating or completing this vaccine series.
*Referral for speech pathology*
- Saying "a few words" at 12 months is **within the normal developmental milestone** for expressive language at this age.
- A referral for **speech pathology** would generally be indicated for more significant language delays.
Multi-drug resistant organism transmission US Medical PG Question 4: A 42-year-old woman with a history of multiple sclerosis and recurrent urinary tract infections comes to the emergency department because of flank pain and fever. Her temperature is 38.8°C (101.8°F). Examination shows left-sided costovertebral angle tenderness. She is admitted to the hospital and started on intravenous vancomycin. Three days later, her symptoms have not improved. Urine culture shows growth of Enterococcus faecalis. Which of the following best describes the most likely mechanism of antibiotic resistance in this patient?
- A. Increased efflux across bacterial cell membranes
- B. Production of beta-lactamase
- C. Alteration of penicillin-binding proteins
- D. Alteration of peptidoglycan synthesis (Correct Answer)
- E. Alteration of ribosomal targets
Multi-drug resistant organism transmission Explanation: ***Alteration of peptidoglycan synthesis***
- **Vancomycin** targets the **D-Ala-D-Ala terminus** on the peptidoglycan precursor, preventing cross-linking during bacterial cell wall synthesis.
- **Vancomycin resistance in Enterococcus faecalis** occurs through acquisition of resistance genes (vanA, vanB) that encode enzymes modifying the peptidoglycan precursor from **D-Ala-D-Ala to D-Ala-D-Lac**.
- This structural change reduces vancomycin's binding affinity by approximately 1000-fold, rendering the antibiotic ineffective.
- The mechanism directly involves **alteration of the peptidoglycan synthesis pathway**, specifically the terminal amino acid residues of the pentapeptide precursor.
*Increased efflux across bacterial cell membranes*
- This mechanism involves **efflux pumps that actively transport antibiotics out of the bacterial cell**, reducing intracellular concentration.
- While efflux pumps contribute to resistance for antibiotics like **tetracyclines, fluoroquinolones, and macrolides**, this is not the primary mechanism of vancomycin resistance in Enterococcus.
*Production of beta-lactamase*
- **Beta-lactamase enzymes** hydrolyze the **beta-lactam ring** of antibiotics like **penicillins and cephalosporins**, rendering them inactive.
- **Vancomycin is a glycopeptide antibiotic, not a beta-lactam**, so its efficacy is not affected by beta-lactamase production.
*Alteration of ribosomal targets*
- This mechanism confers resistance to antibiotics that target **bacterial ribosomes** to inhibit protein synthesis, such as **macrolides, aminoglycosides, and tetracyclines**.
- **Vancomycin acts on cell wall synthesis**, not protein synthesis, so alteration of ribosomal targets is not relevant to vancomycin resistance.
*Alteration of penicillin-binding proteins*
- **Penicillin-binding proteins (PBPs)** are the targets of **beta-lactam antibiotics** (penicillins, cephalosporins, carbapenems).
- Alterations in PBPs cause resistance to beta-lactams, not to vancomycin.
- **Vancomycin does not interact with PBPs**; it binds directly to the D-Ala-D-Ala terminus of peptidoglycan precursors in the cell wall.
Multi-drug resistant organism transmission US Medical PG Question 5: A team of intensivists working in a private intensive care unit (ICU) observe that the clinical efficacy of vancomycin is low, and proven nosocomial infections have increased progressively over the past year. A clinical microbiologist is invited to conduct a bacteriological audit of the ICU. He analyzes the microbiological reports of all patients treated with vancomycin over the last 2 years and takes relevant samples from the ICU for culture and antibiotic sensitivity analysis. The audit concludes that there is an increased incidence of vancomycin-resistant Enterococcus fecalis infections. Which of the following mechanisms best explains the changes that took place in the bacteria?
- A. Decreased number of porins in the bacterial cell wall leading to decreased intracellular entry of the antibiotic
- B. Production of an enzyme that hydrolyzes the antibiotic
- C. Protection of the antibiotic-binding site by Qnr protein
- D. Increased expression of efflux pumps which extrude the antibiotic from the bacterial cell
- E. Replacement of the terminal D-Ala in the cell wall peptidoglycan by D-lactate (Correct Answer)
Multi-drug resistant organism transmission Explanation: ***Replacement of the terminal D-ala in the cell wall peptidoglycan by D-lactate***
- **Vancomycin** exerts its antibacterial effect by binding to the **D-Ala-D-Ala** terminus of the peptidoglycan precursor in the bacterial cell wall, preventing its incorporation.
- In **vancomycin-resistant Enterococcus (VRE)**, the D-Ala-D-Ala is replaced by **D-Ala-D-Lac**, which significantly reduces vancomycin's binding affinity, leading to resistance.
*Decreased number of porins in the bacterial cell wall leading to decreased intracellular entry of the antibiotic*
- This mechanism primarily affects **Gram-negative bacteria**, where porins are crucial for antibiotic entry through the outer membrane.
- **Enterococcus faecalis** is a **Gram-positive bacterium** and does not rely on porins in the same way for vancomycin uptake.
*Production of an enzyme that hydrolyzes the antibiotic*
- This mechanism is characteristic of resistance to **beta-lactam antibiotics** (e.g., penicillinases, cephalosporinases).
- Vancomycin is not a beta-lactam, and its resistance mechanism in Enterococcus does not typically involve enzymatic hydrolysis.
*Protection of the antibiotic-binding site by Qnr protein*
- **Qnr proteins** are associated with **quinolone resistance**, specifically by protecting DNA gyrase and topoisomerase IV from quinolone inhibition.
- This mechanism is irrelevant to vancomycin, which targets the bacterial cell wall.
*Increased expression of efflux pumps which extrude the antibiotic from the bacterial cell*
- Efflux pumps are a common mechanism of antibiotic resistance against a wide range of antibiotics, including **tetracyclines, macrolides, and fluoroquinolones**.
- While efflux pumps can contribute to some forms of resistance, they are not the primary or best-explained mechanism for **high-level vancomycin resistance in Enterococcus**.
Multi-drug resistant organism transmission US Medical PG Question 6: A 63-year-old female recovering from a total shoulder arthroplasty completed 6 days ago presents complaining of joint pain in her repaired shoulder. Temperature is 39 degrees Celsius. Physical examination demonstrates erythema and significant tenderness around the incision site. Wound cultures reveal Gram-positive cocci that are resistant to nafcillin. Which of the following organisms is the most likely cause of this patient's condition?
- A. Streptococcus pyogenes
- B. Escherichia coli
- C. Streptococcus viridans
- D. Staphylococcus epidermidis
- E. Staphylococcus aureus (Correct Answer)
Multi-drug resistant organism transmission Explanation: ***Staphylococcus aureus***
- The combination of **post-surgical infection**, **erythema**, and fever with **Gram-positive cocci** that are **nafcillin-resistant** is highly indicative of **Methicillin-Resistant Staphylococcus aureus (MRSA)**.
- *S. aureus* is a common cause of **surgical site infections**, and its resistance to nafcillin implies it is MRSA, a significant clinical concern for its difficulty in treatment.
*Streptococcus pyogenes*
- While *S. pyogenes* is a Gram-positive coccus that can cause skin and soft tissue infections, it is typically **susceptible to penicillin** and related antibiotics like nafcillin, unlike the organism described.
- It is more commonly associated with **streptococcal pharyngitis** or **cellulitis**, and while it can cause severe disease, its resistance profile doesn't match the clinical picture.
*Escherichia coli*
- *E. coli* is a **Gram-negative rod**, not a Gram-positive coccus.
- It is a common cause of **urinary tract infections** and **gastrointestinal infections**, making it an unlikely pathogen for a post-surgical joint infection unless contaminated from a visceral source.
*Streptococcus viridans*
- **Viridans streptococci** are Gram-positive cocci but are typically associated with **endocarditis** or dental infections, especially after poor dental hygiene or procedures.
- They are usually **susceptible to penicillin** and do not typically exhibit nafcillin resistance as the primary feature in a post-arthroplasty infection.
*Staphylococcus epidermidis*
- *S. epidermidis* is a **coagulase-negative Staphylococcus** known for forming **biofilms on prosthetic devices**, leading to chronic, low-grade infections.
- While it can be nafcillin-resistant, the **acute presentation** with fever and significant inflammation suggests a more virulent pathogen like *S. aureus*, as *S. epidermidis* infections are typically indolent.
Multi-drug resistant organism transmission US Medical PG Question 7: A 55-year-old man presents to the physician with complaints of 5 days of watery diarrhea, fever, and bloating. He has not noticed any blood in his stool. He states that his diet has not changed recently, and his family has been spared from diarrhea symptoms despite eating the same foods that he has been cooking at home. He has no history of recent travel outside the United States. His only medication is high-dose omeprazole, which he has been taking daily for the past few months to alleviate his gastroesophageal reflux disease (GERD). Which of the following is the most appropriate initial test to work up this patient’s symptoms?
- A. Stool toxin assay (Correct Answer)
- B. Colonoscopy
- C. Fecal occult blood test
- D. Stool culture
- E. Stool ova and parasite
Multi-drug resistant organism transmission Explanation: ***Stool toxin assay***
- The patient's presentation of **watery diarrhea** and fever, especially with a history of **high-dose omeprazole use**, strongly suggests **Clostridioides difficile infection**.
- **Omeprazole** (a proton pump inhibitor) reduces stomach acid, which can disrupt the normal gut flora and increase susceptibility to *C. difficile*; a **stool toxin assay** is the most direct diagnostic test for this infection.
*Colonoscopy*
- While a colonoscopy can visualize pseudomembranes associated with severe *C. difficile* colitis, it is an **invasive procedure** and not the initial diagnostic test of choice for suspected infectious diarrhea.
- It is usually reserved for cases with atypical presentations, suspected complications, or when other diagnostic tests are inconclusive.
*Fecal occult blood test*
- The patient describes **watery diarrhea** and specifically states he has **not noticed any blood in his stool**, making a fecal occult blood test unlikely to be helpful in this acute setting.
- This test is primarily used for screening **colorectal cancer** or identifying chronic gastrointestinal bleeding.
*Stool culture*
- A stool culture primarily identifies bacterial pathogens like *Salmonella*, *Shigella*, or *Campylobacter*, which typically cause diarrheal illnesses that may include **bloody stools** or have specific epidemiological links (e.g., foodborne outbreaks).
- Given the history of **omeprazole use** and the absence of blood, *C. difficile* is more likely than these common bacterial enteritides, and a stool culture does not detect *C. difficile* itself.
*Stool ova and parasite*
- This test is used to detect **parasitic infections** (e.g., Giardia, Cryptosporidium), which can cause watery diarrhea and bloating.
- However, given the specific risk factor of **omeprazole use**, **Clostridioides difficile** infection is a more probable diagnosis, making the stool toxin assay the more appropriate initial test.
Multi-drug resistant organism transmission US Medical PG Question 8: A 35-year-old female presents to the emergency room complaining of diarrhea and dehydration. She has been experiencing severe watery diarrhea for the past 3 days. She reports that she has been unable to leave the bathroom for more than a few minutes at a time. The diarrhea is profuse and watery without visible blood or mucus. She recently returned from a volunteer trip to Yemen where she worked at an orphanage. Her past medical history is notable for psoriasis for which she takes sulfasalazine. The patient drinks socially and does not smoke. Her temperature is 99°F (37.2°C), blood pressure is 100/55 mmHg, pulse is 130/min, and respirations are 20/min. Mucous membranes are dry. Her eyes appear sunken. Capillary refill is 4 seconds. The patient is started on intravenous fluid resuscitation. Which of the following processes is capable of transmitting the genetic material for the toxin responsible for this patient's condition?
- A. Transposition
- B. Conjugation
- C. Endospore formation
- D. Transduction (Correct Answer)
- E. Transformation
Multi-drug resistant organism transmission Explanation: ***Transduction***
- The patient's symptoms are highly suggestive of **cholera**, caused by *Vibrio cholerae*, which produces **cholera toxin**.
- The genes for cholera toxin are carried on a **bacteriophage (CTXφ)**, and their transfer between bacteria occurs via **transduction**.
*Transposition*
- **Transposition** involves the movement of **transposons ("jumping genes")** within a genome or between DNA molecules.
- While transposons can carry antimicrobial resistance genes or virulence factors, this mechanism is not typically associated with the transfer of the primary cholera toxin genes.
*Conjugation*
- **Conjugation** is the transfer of genetic material between bacteria through direct cell-to-cell contact, often involving a **pilus** and the transfer of **plasmids**.
- While *Vibrio cholerae* can engage in conjugation, the cholera toxin genes are predominantly acquired via specialized transduction with the CTXφ phage, not typically plasmid-mediated conjugation.
*Endospore formation*
- **Endospore formation** is a survival mechanism used by certain bacteria (e.g., *Clostridium*, *Bacillus*) to withstand harsh environmental conditions.
- It is not a mechanism for **horizontal gene transfer** or the transmission of toxin-encoding genetic material between bacteria.
*Transformation*
- **Transformation** is the uptake of **naked DNA** from the environment by a bacterial cell.
- While *Vibrio cholerae* can be naturally competent for transformation, the cholera toxin genes are primarily acquired through **phage-mediated transduction**, not free DNA uptake.
Multi-drug resistant organism transmission US Medical PG Question 9: A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
- A. "Does the diarrhea typically precede the constipation, or vice-versa?"
- B. "Is the diarrhea foul-smelling?"
- C. "Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"
- D. "Are the symptoms worse in the morning or at night?"
- E. "Can you tell me more about the symptoms you have been experiencing?" (Correct Answer)
Multi-drug resistant organism transmission Explanation: ***Can you tell me more about the symptoms you have been experiencing?***
- This **open-ended question** encourages the patient to provide a **comprehensive narrative** of their symptoms, including details about onset, frequency, duration, alleviating/aggravating factors, and associated symptoms, which is crucial for diagnosis.
- In a patient presenting with vague, intermittent symptoms like alternating constipation and diarrhea, allowing them to elaborate freely can reveal important clues that might not be captured by more targeted questions.
*Does the diarrhea typically precede the constipation, or vice-versa?*
- While knowing the sequence of symptoms can be helpful in understanding the **pattern of bowel dysfunction**, it is a very specific question that might overlook other important aspects of the patient's experience.
- It prematurely narrows the focus without first obtaining a broad understanding of the patient's overall symptomatic picture.
*Is the diarrhea foul-smelling?*
- Foul-smelling diarrhea can indicate **malabsorption** or **bacterial overgrowth**, which are important to consider in some gastrointestinal conditions.
- However, this is a **specific symptom inquiry** that should follow a more general exploration of the patient's symptoms, as it may not be relevant if other crucial details are missed.
*Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life*
- Quantifying pain intensity is useful for assessing the **severity of discomfort** and monitoring changes over time.
- However, for a patient with intermittent rather than acute, severe pain, understanding the **character, location, and triggers** of the pain is often more diagnostically valuable than just a numerical rating initially.
*Are the symptoms worse in the morning or at night?*
- Diurnal variation can be relevant in certain conditions, such as inflammatory bowel diseases where nocturnal symptoms might be more concerning, or functional disorders whose symptoms might be stress-related.
- This is another **specific question** that should come after gathering a more complete initial picture of the patient's symptoms to ensure no key information is overlooked.
Multi-drug resistant organism transmission US Medical PG Question 10: A 27-year-old pregnant woman presents to an obstetrician at 35 weeks gestation reporting that she noted the presence of a mucus plug in her vaginal discharge this morning. The obstetrician performs an examination and confirms that she is in labor. She was diagnosed with HIV infection 1 year ago. Her current antiretroviral therapy includes abacavir, lamivudine, and nevirapine. Her last HIV RNA level was 2,000 copies/mL 3 weeks ago. Which of the following anti-retroviral drugs should be administered intravenously to the woman during labor?
- A. Enfuvirtide
- B. Nevirapine
- C. Abacavir
- D. Rilpivirine
- E. Zidovudine (Correct Answer)
Multi-drug resistant organism transmission Explanation: ***Zidovudine***
- Intravenous **zidovudine** is recommended during labor for HIV-positive pregnant women, especially when the viral load is **>1000 copies/mL**, to reduce the risk of **mother-to-child transmission (MTCT)**.
- This intervention significantly lowers the viral load in the maternal blood and reduces fetal exposure to the virus during delivery.
*Enfuvirtide*
- **Enfuvirtide** is a **fusion inhibitor** administered subcutaneously, not intravenously, and is reserved for treatment-experienced patients with multi-drug resistant HIV.
- It is not a standard recommendation for intrapartum prophylaxis against MTCT.
*Nevirapine*
- **Nevirapine** is an **NNRTI** that is typically given orally, and while it has been used for MTCT prophylaxis, intravenous administration is not standard for intrapartum use.
- The woman is already on oral nevirapine as part of her ART regimen.
*Abacavir*
- **Abacavir** is an **NRTI** given orally and is part of the patient's current ART regimen.
- It is not administered intravenously for intrapartum MTCT prophylaxis.
*Rilpivirine*
- **Rilpivirine** is an **NNRTI** that is taken orally and is not indicated for intravenous administration during labor to prevent MTCT.
- Its use is limited by potential drug interactions and efficacy in patients with high viral loads.
More Multi-drug resistant organism transmission US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
